Affymax, Inc. (NASDAQ: AFFY) today announced completion of treatment and follow-up of patients with anemia due to chronic renal failure ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE